Savio L.C. Woo

21.2k total citations · 1 hit paper
282 papers, 17.5k citations indexed

About

Savio L.C. Woo is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Savio L.C. Woo has authored 282 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Molecular Biology, 123 papers in Genetics and 76 papers in Clinical Biochemistry. Recurrent topics in Savio L.C. Woo's work include Virus-based gene therapy research (87 papers), Metabolism and Genetic Disorders (76 papers) and Animal Genetics and Reproduction (36 papers). Savio L.C. Woo is often cited by papers focused on Virus-based gene therapy research (87 papers), Metabolism and Genetic Disorders (76 papers) and Animal Genetics and Reproduction (36 papers). Savio L.C. Woo collaborates with scholars based in United States, Germany and Denmark. Savio L.C. Woo's co-authors include Bert W. O’Malley, Fred D. Ledley, Anthony G. DiLella, Milton J. Finegold, Randy C. Eisensmith, T.S. Chandra, Shu‐Hsia Chen, Mark A. Kay, Vincent J. Kidd and Katsunori Shinozaki and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Savio L.C. Woo

279 papers receiving 16.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of definitive endoderm from embryonic stem cells in culture

2004 650 citations Katsunori Shinozaki, Savio L.C. Woo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Savio L.C. Woo United States	76	10.9k	6.9k	3.0k	2.6k	1.6k	282	17.5k
Karl V. Voelkerding United States	32	11.2k 1.0×	9.8k 1.4×	1.0k 0.3×	1.6k 0.6×	1.7k 1.1×	86	23.1k
Markus Grompe United States	83	17.3k 1.6×	7.0k 1.0×	1.3k 0.4×	3.7k 1.4×	8.0k 5.1×	273	28.6k
John W. Belmont United States	60	6.6k 0.6×	5.3k 0.8×	324 0.1×	709 0.3×	1.3k 0.8×	217	14.4k
Lap‐Chee Tsui Canada	57	5.8k 0.5×	2.8k 0.4×	894 0.3×	619 0.2×	1.2k 0.8×	145	12.6k
F.H. Ruddle United States	64	8.0k 0.7×	4.2k 0.6×	299 0.1×	1.2k 0.5×	534 0.3×	229	12.5k
Ulf Hellman Sweden	63	9.4k 0.9×	1.1k 0.2×	339 0.1×	1.8k 0.7×	817 0.5×	280	14.3k
Günter J. Hämmerling Germany	79	5.7k 0.5×	1.5k 0.2×	740 0.2×	4.3k 1.6×	893 0.6×	232	19.7k
Moshé Yaniv France	90	18.6k 1.7×	6.6k 1.0×	208 0.1×	4.2k 1.6×	3.7k 2.4×	296	26.7k
Victor Koteliansky United States	57	10.3k 0.9×	1.2k 0.2×	340 0.1×	1.8k 0.7×	1.5k 1.0×	125	17.2k
Hiroto Okayama Japan	53	14.4k 1.3×	3.1k 0.5×	196 0.1×	2.8k 1.1×	673 0.4×	136	20.7k

Countries citing papers authored by Savio L.C. Woo

Since Specialization

Citations

This map shows the geographic impact of Savio L.C. Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Savio L.C. Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Savio L.C. Woo more than expected).

Fields of papers citing papers by Savio L.C. Woo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Savio L.C. Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Savio L.C. Woo. The network helps show where Savio L.C. Woo may publish in the future.

Co-authorship network of co-authors of Savio L.C. Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Savio L.C. Woo. A scholar is included among the top collaborators of Savio L.C. Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Savio L.C. Woo. Savio L.C. Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Eisenstein, Samuel, Brian A. Coakley, Karen Briley‐Sæbø, et al.. (2013). Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy. Cancer Research. 73(16). 5003–5015. 64 indexed citations

2.

Shinozaki, Katsunori, Takemasa Sakaguchi, Marcia Meseck, et al.. (2012). The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer. International Journal of Molecular Medicine. 31(2). 299–306. 19 indexed citations

3.

Bonadio, Jeffrey, Savio L.C. Woo, Katherine A. High, et al.. (2002). Genetic Approaches to Tissue Engineering. Annals of the New York Academy of Sciences. 961(1). 71–72. 1 indexed citations

4.

Bhoumik, Anindita, Tiangui Huang, Vladimir N. Ivanov, et al.. (2002). An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. Journal of Clinical Investigation. 110(5). 643–650. 59 indexed citations

5.

Bhoumik, Anindita, Tiangui Huang, Vladimir N. Ivanov, et al.. (2002). An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. Journal of Clinical Investigation. 110(5). 643–650. 7 indexed citations

6.

Attur, Mukundan, Mandar Dave, Christine Cipolletta, et al.. (2002). Functional Genomic Analysis of Type II IL-1β Decoy Receptor: Potential for Gene Therapy in Human Arthritis and Inflammation. The Journal of Immunology. 168(4). 2001–2010. 51 indexed citations

7.

Gelovani, Juri G., S H Chen, Arjun S. Joshi, et al.. (1999). Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.. PubMed. 59(20). 5186–93. 131 indexed citations

8.

Rojas-Martı́nez, Augusto, Philip R. Wyde, Charles A. Montgomery, et al.. (1999). Distribution, persistency, toxicity, and lack of replication of an E1A-deficient adenoviral vector after intracardiac delivery in the cotton rat.. PubMed. 5(6). 365–70. 10 indexed citations

9.

Herman, James R., Howard L. Adler, Estuardo Aguilar-Córdova, et al.. (1999). In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical Trial. Human Gene Therapy. 10(7). 1239–1250. 235 indexed citations

10.

Muzzin, Patrick, Randy C. Eisensmith, Kenneth C. Copeland, & Savio L.C. Woo. (1997). Hepatic Insulin Gene Expression as Treatment for Type 1 Diabetes Mellitus in Rats. Molecular Endocrinology. 11(6). 833–837. 52 indexed citations

11.

Smith, Louis C., Randy C. Eisensmith, & Savio L.C. Woo. (1995). Gene Therapy in Heart Disease. Advances in experimental medicine and biology. 369. 79–88. 6 indexed citations

12.

Eisensmith, Randy C. & Savio L.C. Woo. (1995). 6 Molecular Genetics of Phenylketonuria: From Molecular Anthropology to Gene Therapy. Advances in genetics. 32. 199–271. 22 indexed citations

13.

Kay, Mark A. & Savio L.C. Woo. (1994). Gene therapy for metabolic disorders. Trends in Genetics. 10(7). 253–257. 82 indexed citations

14.

Kay, Mark A., Qiutang Li, Ta-Jen Liu, et al.. (1992). Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo. Human Gene Therapy. 3(6). 641–647. 155 indexed citations

15.

Avigad, Smadar, Sandra E. Kleiman, B. E. Cohen, et al.. (1991). Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria.. PubMed. 49(2). 393–9. 26 indexed citations

16.

Clift, S, et al.. (1989). Tissue-Specific Regulation of Human α ₁ -Antitrypsin Gene Expression in Transgenic Mice. DNA. 8(2). 101–108. 25 indexed citations

17.

McDonald, J. David, Richard G.H. Cotton, Ian G. Jennings, et al.. (1988). Biochemical Defect of the hph‐1 Mouse Mutant Is a Deficiency in GTP‐Cyclohydrolase Activity. Journal of Neurochemistry. 50(2). 655–657. 51 indexed citations

18.

DiLella, Anthony G. & Savio L.C. Woo. (1987). [49] Hybridization of genomic DNA to oligonucleotide probes in the presence of tetramethylammonium chloride. Methods in enzymology on CD-ROM/Methods in enzymology. 152. 447–451. 72 indexed citations

19.

Woo, Savio L.C.. (1984). Prenatal Diagnosis and Carrier Detection of Classic Phenylketonuria by Gene Analysis. PEDIATRICS. 74(3). 412–423. 14 indexed citations

20.

Chandra, T.S., David W. Bullock, & Savio L.C. Woo. (1981). Hormonally Regulated Mammalian Gene Expression: Steady-State Level and Nucleotide Sequence of Rabbit Uteroglobin mRNA. DNA. 1(1). 19–26. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact